Using AI to break the opioid addiction cycle

When Ben Brown, research assistant professor of chemistry, thinks about the opioid epidemic, he views the problem on a molecular level.

Neuvivo makes bid to enter ALS arena with immunotherapy candidate – Pharmaceutical Technology

NP001 is designed to reestablish the balance of pro- and anti-inflammatory processes. Credits: David Herraez Calzada/Shutterstock.com Neuvivo has submitted a New Drug Application (NDA) for

October 7, 2024

SSRIs and SNRIs Weaken Psilocybin’s Effects, New Study Finds

As psilocybin gains prominence in treating affective disorders like treatment-resistant depression and major depressive disorder, and advanced clinical trials aim to prove that the active

July 20, 2023

Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis

Gene therapy for hemophilia B allowed almost three-fourths of patients to discontinue prophylactic factor IX therapy with no increase in bleeding, results of the pivotal

September 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.